This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum ...

Testosterone replacement therapy, also known as TRT, has surged in popularity, but there are potential risks. Here's what to ...

Senior Editor Dana Dickey and Associate Editor of News and Entertainment Nakeisha Campbell sit down to discuss their thoughts ...

New research on AI Overviews and organic search results presents a fresh view on how AIO is evolving and suggests how to ...

Awareness Day, observed every year on the last Wednesday of February, is a chance to shine a light on a heart condition that ...

1. Toxic shock syndrome isn’t a myth — it is very real — but I don’t think briefly stuffing someone’s panties in her vagina ...

The recent enforcement action by the Health Ministry (MOH) against misleading cosmetic advertisements, particularly those ...

This would be Dermata's second patent for DMT410, if issued, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial ...

I’m a cis man in a monogamous relationship with a cis woman who is going through perimenopause. She was recently prescribed a ...

Dermata Therapeutics (DRMA) announced the Australian Patent Office has accepted its patent application for its DMT410 program for the treatment ...